TCV-309 chloride

发表于由

上海金畔生物科技有限公司为生命科学和医药研发人员提供生物活性分子抑制剂、激动剂、特异性抑制剂、化合物库、重组蛋白，专注于信号通路和疾病研究领域。

TCV-309 chloride  纯度: ≥98.0%

TCV-309 chloride 是一种有效的，特异性血小板活化因子 (PAF) 拮抗剂。TCV-309 chloride 特异性地抑制 PAF 诱导的兔和人血小板聚集，以及 [3H]PAF 与兔血小板微粒体的结合，IC50 值分别为 33 nM，58 nM 和 27 nM。TCV-309 chloride 对过敏性休克具有有益作用。

TCV-309 chloride

TCV-309 chloride Chemical Structure

CAS No. : 121494-09-5

规格 价格 是否有货 数量
10 mM * 1 mL in DMSO ￥4851 In-stock
5 mg ￥2800 In-stock
10 mg ￥4400 In-stock
25 mg ￥8800 In-stock
50 mg ￥14000 In-stock
100 mg   询价  
200 mg   询价  

* Please select Quantity before adding items.

TCV-309 chloride 相关产品

•相关化合物库:

  • Bioactive Compound Library Plus
  • Anti-Cancer Compound Library
  • Targeted Diversity Library

生物活性

TCV-309 chloride is a potent and specific platelet activating factor (PAF) antagonist. TCV-309 chloride specifically inhibits PAF-induced aggregation of rabbit and human platelets, and [3H]PAF binding to rabbit platelet microsomes with IC50 values of 33 nM, 58 nM and 27 nM, respectively. TCV-309 chloride has beneficial effects in anaphylactic shock[1][2].

体内研究
(In Vivo)

In rats, TCV-309 selectively inhibits the PAF-induced hypotension, hemoconcentration and death with ED50 values of 2.7, 6.4 and 1.7 micrograms/kg (i.v.), respectively. TCV-309 most potently protects mice from death induced by PAF and due to anaphylactic shock with ED50 values of 2.1 and 2.6 micrograms/kg (i.v.), respectively[1].
TCV-309 chloride also reversed PAF-induced hypotension and endotoxin-induced hypotension in rats with ED50 values of 3.3 and 1.2 micrograms/kg (i.v.), respectively[1].

上海金畔生物科技有限公司 has not independently confirmed the accuracy of these methods. They are for reference only.
分子量

629.97

Formula

C30H34BrClN4O4
CAS 号

121494-09-5
运输条件

Room temperature in continental US; may vary elsewhere.
储存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)
溶解性数据
In Vitro: 

DMSO : ≥ 6.3 mg/mL (10.00 mM)

* “≥” means soluble, but saturation unknown.

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 1.5874 mL 7.9369 mL 15.8738 mL
5 mM 0.3175 mL 1.5874 mL 3.1748 mL
10 mM 0.1587 mL 0.7937 mL 1.5874 mL

*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液；一旦配成溶液，请分装保存，避免反复冻融造成的产品失效。
储备液的保存方式和期限：-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)。-80°C 储存时，请在 6 个月内使用，-20°C 储存时，请在 1 个月内使用。
参考文献

  • [1]. Terashita Z et al. Beneficial effects of TCV-309, a novel potent and selective platelet activating factor antagonist in endotoxin and anaphylactic shock in rodents. J Pharmacol Exp Ther. 1992 Feb;260(2):748-55.

    [2]. M Poeze, et al. Decreased organ failure in patients with severe SIRS and septic shock treated with the platelet-activating factor antagonist TCV-309: a prospective, multicenter, double-blind, randomized phase II trial. TCV-309 Septic Shock Study Group. Shock. 2000 Oct;14(4):421-8.

所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务